Company Profiles

driven by the PitchBook Platform

Aferrix

Description

Developer of technology for early diagnosis and monitoring of toxic iron in the serum. The company has developed a novel technology for the diagnosis and monitoring of iron toxicity and overload in bodily fluids.

2002

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

2

Investors

Description

Developer of technology for early diagnosis and monitoring of toxic iron in the serum. The company has developed a novel technology for the diagnosis and monitoring of iron toxicity and overload in bodily fluids.

Website:

www.aferrix.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Monitoring Equipment
Biotechnology

Primary Office

Kiryat Atidim Building 3 Tel Aviv 69710Israel +972 (0)73 212 6155
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aferrix's full profile, request a free trial.

    Aferrix Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aferrix Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Biomedix IncubatorAccelerator/IncubatorMinority000 0000000 0000
    Gefen Biomed InvestmentsVenture CapitalMinority000 0000000 0000
    Biomedix Incubator Accelerator/Incubator
    Gefen Biomed Investments Venture Capital

    Aferrix Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Yael FurmanChief Executive Officer
    Ioav Cabantchik MDFounder & Scientific Advisor
    Yael Furman Chief Executive Officer
    Ioav Cabantchik MD Founder & Scientific Advisor
    Request full access to PitchBook